While TGF-β suppresses cell proliferation and induces apoptosis in healthy and premalignant cells [16], Korkut et al. demonstrated that dysregulation of genes involved in the TGF-β signaling pathway has been implicated in over 50% of tissue samples from 12 different cancer types [17]. Here, TGFB1 is linked to cancer.